JHVEPhoto
Eli Lilly (LLY) CEO Dave Ricks told German business daily Handelsblatt that his company will halve its initially planned €2.3B ($2.7B) investment in Germany as the weight-loss drugmaker focuses its home market in the U.S.
The Indiana-based drugmaker has already
